Cargando…
Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642833/ https://www.ncbi.nlm.nih.gov/pubmed/33194691 http://dx.doi.org/10.3389/fonc.2020.576924 |
_version_ | 1783606161673551872 |
---|---|
author | Pan, Jonathan Altman, Daniel Wilde, Lindsay |
author_facet | Pan, Jonathan Altman, Daniel Wilde, Lindsay |
author_sort | Pan, Jonathan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7642833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76428332020-11-13 Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome Pan, Jonathan Altman, Daniel Wilde, Lindsay Front Oncol Oncology Frontiers Media S.A. 2020-10-22 /pmc/articles/PMC7642833/ /pubmed/33194691 http://dx.doi.org/10.3389/fonc.2020.576924 Text en Copyright © 2020 Pan, Altman and Wilde http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Pan, Jonathan Altman, Daniel Wilde, Lindsay Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome |
title | Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome |
title_full | Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome |
title_fullStr | Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome |
title_full_unstemmed | Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome |
title_short | Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome |
title_sort | measurable residual disease-guided treatment to prevent relapse in acute myeloid leukemia and myelodysplastic syndrome |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642833/ https://www.ncbi.nlm.nih.gov/pubmed/33194691 http://dx.doi.org/10.3389/fonc.2020.576924 |
work_keys_str_mv | AT panjonathan measurableresidualdiseaseguidedtreatmenttopreventrelapseinacutemyeloidleukemiaandmyelodysplasticsyndrome AT altmandaniel measurableresidualdiseaseguidedtreatmenttopreventrelapseinacutemyeloidleukemiaandmyelodysplasticsyndrome AT wildelindsay measurableresidualdiseaseguidedtreatmenttopreventrelapseinacutemyeloidleukemiaandmyelodysplasticsyndrome |